(Q38184908)

30 August 2017

Clinical relevance of circulating cell-free microRNAs in cancer (English)

1 reference

30 August 2017

1 reference

3

George A Calin

1 reference

30 August 2017

Heidi Schwarzenbach

1

1 reference

30 August 2017

Naohiro Nishida

series ordinal

2

1 reference

30 August 2017

Klaus Pantel

series ordinal

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

4 February 2014

1 reference

Nature Reviews Clinical Oncology

30 August 2017

1 reference

30 August 2017

11

1 reference

30 August 2017

3

1 reference

30 August 2017

145-156

1 reference

MicroRNA profiling: approaches and considerations

30 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNAs in body fluids--the mix of hormones and biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Extracellular miRNAs: the mystery of their origin and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA biogenesis: coordinated cropping and dicing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The widespread regulation of microRNA biogenesis, function and decay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNAs: target recognition and regulatory functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The Argonaute protein family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Small RNA and transcriptional upregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA-373 induces expression of genes with complementary promoter sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Switching from repression to activation: microRNAs can up-regulate translation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Emerging complexity of microRNA generation cascades.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Oncomirs - microRNAs with a role in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNAs in immune regulation--opportunities for cancer immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The Role of MicroRNAs in Regulatory T Cells and in the Immune Response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

microRNAs: new ways to block tumor angiogenesis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Functional delivery of viral miRNAs via exosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Lipid-based carriers of microRNAs and intercellular communication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA expression profiles classify human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

A microRNA expression signature of human solid tumors defines cancer gene targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA signature predicts survival and relapse in lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The shaping and functional consequences of the microRNA landscape in breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNAs as stable blood-based markers for cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Characterization of extracellular circulating microRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Real-time quantification of microRNAs by stem-loop RT-PCR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Next-generation DNA sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Genetic variation in microRNA networks: the implications for cancer research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

miRNA arm selection and isomiR distribution in gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA-21 gene and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Cell-free nucleic acids as biomarkers in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating tumor cells as therapy-related biomarkers in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Tumor cell dissemination: emerging biological insights from animal models and cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miRNAs are correlated with tumor progression in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNAs predict biochemical recurrence in prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Changes in circulating microRNA levels associated with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Upper gastrointestinal cancer predisposition syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Aberrant expression of miR-196a in gastric cancers and correlation with recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNAs are promising novel biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA-155 as a potential biomarker to track disease in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating MiR-125b as a marker predicting chemoresistance in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Complexity of the microRNA repertoire revealed by next-generation sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Targeting microRNAs in cancer: rationale, strategies and challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Treatment of HCV infection by targeting microRNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

31 March 2020

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

A plasma microRNA panel for early detection of colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2014.5

Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

31 March 2020

1 reference

12 December 2020

Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer

1 reference

12 December 2020

Plasma microRNAs as novel biomarkers for early detection of lung cancer

1 reference

12 December 2020

Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures

1 reference

12 December 2020

MicroRNAs as Novel Biomarkers for Breast Cancer

1 reference

12 December 2020

MicroRNA: function, detection, and bioanalysis.

1 reference

12 December 2020

Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer

1 reference

12 December 2020

Comprehensive analysis of microRNAs in breast cancer

1 reference

12 December 2020

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

1 reference

12 December 2020

Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.

1 reference

12 December 2020

Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCLINONC.2014.5

1 reference

30 August 2017

1 reference